IQVIA Introduces RIM Smart, the Industry’s First Fully Integrated, End-to-End Regulatory Information Management System

More than regulatory information management (RIM), IQVIA RIM Smart
delivers intelligent, interconnected global management across the
complete portfolio and regulatory lifecycle

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA
(NYSE:IQV) today announced the launch of IQVIA RIM Smart, the first
fully integrated, cloud-based, end-to-end regulatory information
management solution for life sciences. Designed to leverage artificial
intelligence (AI) and machine learning (ML), IQVIA Technologies’ new
solution enables intelligent management of a product portfolio’s
complete regulatory lifecycle.

“Life sciences companies are challenged by an increasingly complex,
rapidly changing global regulatory environment within challenging
financial constraints,” said Tal Rosenberg, senior vice president,
Global Technology Solutions for IQVIA. “IQVIA RIM Smart is a
technology-led solution for increasing speed, collaboration between
functions, efficiency, and visibility across the full product portfolio,
while also improving compliance performance.”

RIM Smart automates high-volume tasks, efficiently boosting accuracy,
improving data quality, and reducing costs. This unique solution
incorporates up-to-date regulatory intelligence information through the
software, providing specific and detailed country-level regulatory
requirements. Using an array of fully integrated modules that can be
customized to meet specific customer needs, RIM Smart is appropriate for
companies of all sizes.

“Built for regulatory professionals by regulatory professionals, RIM
Smart will seamlessly integrate with IQVIA Technologies’ safety and
quality compliance solutions. A range of open integration options gives
customers the flexibility to plug and play, leveraging existing IT
investments,” said Joe Rymsza, vice president, Pharmacovigilance and
Regulatory Technology Solutions at IQVIA. “Delivered securely in the
cloud and using proprietary AI and ML algorithms, IQVIA RIM Smart will
provide interconnected, comprehensive and intelligent management of the
entire regulatory process.”

More than a regulatory information management system, RIM Smart will
provide content management, registration tracking, monitoring of health
authority interactions and commitments, submission planning, publishing,
and soon, product labeling and translation capabilities. It easily
handles routine workflows, enabling clients to use their resources to
focus on bringing safe and effective products to market and ultimately
driving healthcare forward. For more information visit http://iqvia.com.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics,
technology solutions and contract research services to the life sciences
industry. Formed through the merger of IMS Health and Quintiles, IQVIA
applies human data science — leveraging the analytic rigor and clarity
of data science to the ever-expanding scope of human science — to enable
companies to reimagine and develop new approaches to clinical
development and commercialization, speed innovation and accelerate
improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA
delivers unique and actionable insights at the intersection of
large-scale analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 58,000
employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The
company uses a wide variety of privacy-enhancing technologies and
safeguards to protect individual privacy while generating and analyzing
information on a scale that helps healthcare stakeholders identify
disease patterns and correlate with the precise treatment path and
therapy needed for better outcomes. IQVIA’s insights and execution
capabilities help biotech, medical device and pharmaceutical companies,
medical researchers, government agencies, payers and other healthcare
stakeholders tap into a deeper understanding of diseases, human
behaviors and scientific advances, in an effort to advance their path
toward cures. To learn more, visit www.iqvia.com.

Click
here to subscribe to Mobile Alerts for IQVIA
.

IQVIAFIN

Contacts

Tor Constantino, IQVIA Media Relations ([email protected])
+1.484.567.6732

Andrew
Markwick, IQVIA Investor Relations ([email protected])
+1.973.257.7144

error: Content is protected !!